Australian Hemp Giant Ecofibre (EFO) Nears $1 Billion Market Cap Thanks to Ananda CBD Oil

Australian hemp company Econfibre announced that its revenue numbers are unlikely to disappoint this quarter. The company’s revenue increased by 519% and is at $35.6 million, and its net profits increased by 170% to $6 million, according to a report.

The increase may be due to the popularity of its CBD oil at US-based pharmacies. The company has also seen success since Barry Lambert invested. Lambert is ranked as one of the wealthiest persons in Australia, and since his granddaughter was diagnosed with epilepsy, he has advocated for CBD. Prior to investing in Econfibre, Barry and his wife had given $33.7 million to the University of Sydney for cannabinoid therapeutics research.

According to the report, Lambert’s generosity is based on his belief that

“it's an absolute disgrace that you've got kids out there becoming vegetated, all because they can't get extract to medicinal cannabis because traditional medicines don't work for certain conditions”.

Econfibre’s business is doing well, too. The company has over 3,000 pharmacies selling its product, It is also expanding its Kentucky-based operations by building a manufacturing facility, that will also serve as a tourist attraction. Lambert shared in the report that the growth may be “because we're from Kentucky, which is a hemp state and not a marijuana state whereas a lot of our competitors are from Colorado and other places which are actually marijuana states. He added,

“Marijuana is federally illegal in America, whereas hemp is federally legal in all states, albeit with some restrictions on just a couple of states in how you're marketing it.” Marijuana was made legal by the 2018 farm bill.

He also shared that the process for obtaining CBD prescriptions in Australia is not as easy. People must establish their own special clinic, and doctors must work out the regulations so that the prescription can be added to the special access test. He described the process as “unworkable from a commercial point of view.”

Luice Syed

Luice resides in Pune, India and has recently taken up a kinship with freelance writing. For the past few years, he has been working at Springer Nature in the field of Nanobiotechnology. When not analyzing medical literature and scientific research data, Luice enjoys watching and playing football as well as going on a long hike.

Share

Recent Posts

  • Gummies

Condor CBD Gummies – Shocking Customer Scam Concerns?

The Condor CBD Gummies have been the talk of the hemp-derived cannabidiol edibles as of…

2 years ago
  • Guides

Best Delta 8 THC Products – And Why You Need To Try Them

Delta 8 THC is a naturally occurring cannabinoid commonly produced from hemp-derived CBD. It’s relatively…

3 years ago
  • Guides

VidaCap: What To Know About the Best Mushroom Supplements Brand

With more people turning towards natural remedies in recent years, mushroom supplements have taken the…

3 years ago
  • Topicals & Salves

Circle Labs CBD: Legit Hemp Pain Relief Balm That Works?

The Circle Labs CBD Balm is extracted using a cold-infusion process and is an effective…

3 years ago
  • Gummies

Kara’s Orchards CBD Gummies: Safe Full Spectrum Hemp Extract

If anyone is looking for a CBD supplement that is packed with all the necessary…

3 years ago
  • Tinctures & Drops

Sage Elixir CBD: Legit Sage Elixir CBD Oil Tincture or Not?

If anyone has been searching the internet for all the benefits of CBD and where…

3 years ago